SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
202.60    2.60 (1.30%)
Bid:
203.20
Ask:
203.60
Spread: 0.40 (0.197%)
Market Cap: £3.96b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Director Declaration

21 Dec 2020 11:00

RNS Number : 3665J
ConvaTec Group PLC
21 December 2020
 

ConvaTec Director Declaration

Reading, United Kingdom (21 December 2020)

ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Brian May, Non-Executive Director of the Company, has been appointed as Non-Executive Director of Ferguson plc (LSE:FERG), effective 1 January 2021. Upon Mr May's appointment, he will also join the Nominations and Audit Committees.

This announcement is made in accordance with Listing Rule 9.6.14R.

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations &

Corporate Communications, ConvaTec +44 (0)7826 447807

ir@convatec.com

 

Media

Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

 

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNPPGCCPUPUGUG
Date   Source Headline
3rd Nov 20163:25 pmRNSNotification of major interest in shares
31st Oct 20162:45 pmRNSNotification of major interest in shares
31st Oct 20168:09 amRNSAdmission to Trading on the London Stock Exchange
26th Oct 20161:57 pmRNSPublication of a Prospectus
26th Oct 20167:00 amRNSOffer Price Announcement
26th Oct 20167:00 amRNSStabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.